News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Golumbeski George
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 05/31/2023 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
| 01/05/2023 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 2,108 options to buy
@ $39.16, valued at
$82.5k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Bought 28,330 shares
@ $3.63, valued at
$102.8k
|
|
| 04/26/2022 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Bought 26,049 shares
@ $3.69, valued at
$96.1k
Bought 234 shares
@ $3.67, valued at
$858.8 |
|
| 01/05/2022 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 1,638 options to buy
@ $42.21, valued at
$69.1k
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Granted 1,286 options to buy
@ $53.02, valued at
$68.2k
|
|
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $36.47, valued at
$364.7k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 976 options to buy
@ $73.53, valued at
$71.8k
|
|
| 06/06/2019 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $177.41, valued at
$1.8M
|
|
| 03/06/2019 |
4
| Golumbeski George (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 9,280 shares
@ $103.6527, valued at
$961.9k
Exercised 9,280 options to buy
@ $36.61, valued at
$339.7k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Golumbeski George (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $137.29, valued at
$2.7M
|
|
| 03/05/2018 |
4
| Golumbeski George (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $78.62, valued at
$589.7k
|
|
| 02/21/2017 |
4
| Golumbeski George (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $29.02, valued at
$217.7k
|
|
|
|